Riskpilot← Back to searchSign inGet full accessAK Nygart A/S
A/SActiveCVR 26513073Flaskehalsen 17, 3.Hospital activities · NACE 8610Est. 200260 employeeshttps://www.nygart.dk/
Revenue 2024
DKK 46M
+3% vs 2023
EBITDA margin
18.9%
+1% vs 2023
Equity ratio
71.2%
Financial strength
Net profit 2024
DKK 7,7M
-3% vs 2023
| Revenue | DKK 46M | +3% |
| EBITDA | DKK 8,7M | +1% |
| Net profit | DKK 7,7M | -3% |
| Total assets | DKK 87,8M | +8% |
| Equity | DKK 62,5M | +14% |
| Employees | 60 | — |
Legal name
AK Nygart A/S
CVR number
26513073
Legal form
Aktieselskab
NACE code
8610 · Hospital activities
Founded
1. februar 2002
Share capital
DKK 555.556
Employees
60 (FTE)
VAT registered
Yes
Audit selected
Yes
Last report
2024-12-31
Financial year
January – December
Signatory rights
Selskabet tegnes af to bestyrelsesmedlemmer i forening eller af den samlede bestyrelse
Company purpose
Selskabets formål er at drive lægefaglig virksomhed herunder operationer, konsultationer og anden rådgivning samt i øvrigt at drive virksomhed med handel og industri.
Address
Flaskehalsen 17, 3.
Phone
+4570275757
Website
https://www.nygart.dk/
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 19.471 | 22.233 | 23.931 | 29.854 | 33.684 | 31.886 | 38.233 | 49.712 | 53.989 | 41.673 | 36.596 | 44.792 | 45.964 |
| Staff expenses | -14.170 | -17.726 | -21.009 | -21.949 | -24.098 | -21.407 | -26.575 | -33.971 | -34.290 | -32.467 | -31.426 | -36.165 | -36.810 |
| EBITDA | 5.301 | 4.507 | 2.922 | 7.905 | 9.586 | 10.478 | 11.658 | 15.741 | 19.699 | 9.206 | 5.170 | 8.627 | 8.704 |
| Depreciation & amort. | -320 | -545 | -832 | -991 | -1.244 | -1.147 | -1.262 | -1.341 | -1.235 | -1.122 | -1.562 | -1.586 | -2.194 |
| EBIT | 4.981 | 3.962 | 2.090 | 6.914 | 8.341 | 9.331 | 10.396 | 14.400 | 18.464 | 8.084 | 3.608 | 7.041 | 6.510 |
| Net financials | 58 | 84 | -1.403 | -1.461 | 12 | 46 | 335 | 283 | 583 | 1.026 | 1.932 | 3.185 | 3.414 |
| Profit before tax | 5.039 | 4.045 | 687 | 5.453 | 8.353 | 9.377 | 10.731 | 14.684 | 19.047 | 9.111 | 5.539 | 10.226 | 9.924 |
| Tax | 1.276 | 893 | 659 | 1.618 | 1.840 | 2.103 | 2.361 | 3.241 | 4.192 | 1.947 | 1.203 | 2.238 | 2.183 |
| Net profit | 3.763 | 3.152 | 27 | 3.835 | 6.513 | 7.274 | 8.370 | 11.442 | 14.855 | 7.163 | 4.336 | 7.989 | 7.741 |
| Item | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total assets | 10.909 | 15.590 | 14.985 | 19.918 | 14.445 | 22.450 | 32.502 | 48.592 | 66.954 | 69.154 | 70.669 | 81.439 | 87.818 |
| Equity | 2.119 | 4.771 | 3.144 | 6.981 | 3.070 | 7.844 | 8.964 | 20.406 | 35.261 | 42.424 | 46.760 | 54.749 | 62.490 |
| Long-term debt | 0 | 0 | 70 | 55 | 41 | 0 | 0 | 1.220 | 1.154 | 229 | 2.365 | 4.091 | 4.492 |
| Short-term debt | 8.790 | 10.719 | 11.166 | 11.542 | 11.278 | 14.560 | 23.538 | 26.966 | 30.539 | 26.448 | 19.587 | 20.565 | 18.318 |
| Total debt | 8.790 | 10.719 | 11.236 | 11.596 | 11.319 | 14.560 | 23.538 | 28.187 | 31.693 | 26.676 | 21.952 | 24.656 | 22.810 |
EBITDA margin
18.9%
This company
15.8%
Market median
+20% vs market
20122024
Equity ratio
71.2%
This company
38.2%
Market median
+86% vs market
20122024
Return on equity
12.4%
This company
18.4%
Market median
+33% vs market
20122024
Net profit margin
16.8%
This company
8.1%
Market median
+107% vs market
20122024
Asset turnover
0.52×
This company
1.12×
Market median
-54% vs market
20122024
Debt / equity
0.41×
This company
0.62×
Market median
+34% vs market
20122024
- Annual report 2024Filed via CVR / Virk · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via CVR / Virk · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via CVR / Virk · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via CVR / Virk · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via CVR / Virk · Period 2020-01-01 – 2020-12-31
- Annual report 2019Filed via CVR / Virk · Period 2019-01-01 – 2019-12-31
- Annual report 2018Filed via CVR / Virk · Period 2018-01-01 – 2018-12-31
- Annual report 2017Filed via CVR / Virk · Period 2017-01-01 – 2017-12-31
- Annual report 2016Filed via CVR / Virk · Period 2016-01-01 – 2016-12-31
- Annual report 2015Filed via CVR / Virk · Period 2015-01-01 – 2015-12-31
- Annual report 2014Filed via CVR / Virk · Period 2014-01-01 – 2014-12-31
- Annual report 2013Filed via CVR / Virk · Period 2013-01-01 – 2013-12-31
- Annual report 2012Filed via CVR / Virk · Period 2012-01-01 – 2012-12-31
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
HF Chief Executive Officer | Chief Executive Officer | 2025 | — | — |
KB Audit | Audit | 2002 | — | — |
LS Chief Executive Officer | Chief Executive Officer | 2022 | — | — |
VC Management | Management | 2002 | — | — |
JF Management | Management | 2002 | — | — |
Hl Management | Management | 2019 | — | — |
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
| Board of Directors | 2017 | — | — | |
| Board of Directors | 2013 | — | — | |
| Board of Directors | 2005 | — | — | |
| Chairman | 2013 | — | — | |
| Board of Directors | 2018 | — | — | |
| Board of Directors | 2016 | — | — | |
| Deputy Chairman | 2013 | — | — | |
| Board of Directors | 2013 | — | — | |
| Board of Directors | 2013 | — | — | |
| Board of Directors | 2004 | — | — | |
| Board of Directors | 2022 | — | — | |
| Chairman | 2019 | — | — | |
| Chairman | 2007 | — | — | |
| Board of Directors | 2021 | — | — | |
| Chairman | 2025 | — | — | |
| Board of Directors | 2007 | — | — | |
| Chairman | 2016 | — | — | |
| Chairman | 2017 | — | — |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
AKADEMIKLINIKEN DANMARK ApS | Company | 100.0% | 100.0% | 2016 |
Nygart Invest ApS | Company | 66.7% | 100.0% | 2012 |
ERKA INVEST ApS | Company | 10.0% | 0.0% | 2012 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
AKADEMIKLINIKEN DANMARK ApS
AK Nygart A/S Board members of AK Nygart A/S also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Hella Frøjk Harboe | Chief Executive Officer | 0 companies |
| Karl-Alfred Brylle | Audit | 0 companies |
| Louise Skotte Wesselhoff | Chief Executive Officer | 0 companies |
| Victor Christoffersen | Management | 0 companies |
| Jesper Frode Nygart | Management | 0 companies |
| Helle la Cour Hillingsø | Management | 0 companies |
| Peter Östregård | Board of Directors | 0 companies |
| Michaela Pauline Sarah Norland Winther | Board of Directors | 0 companies |
| Morten Eric Nygart | Board of Directors | 0 companies |
| Karin Verland | Chairman | 0 companies |
| Fredrik Lars-Åke Jonsson | Board of Directors | 0 companies |
| Carl Andreas Bertilsson | Board of Directors | 0 companies |
| Lars Anders Almblom Jørgensen | Deputy Chairman | 0 companies |
| Patrizia Christensen | Board of Directors | 0 companies |
| Liselotte Redington Lyngsø | Board of Directors | 0 companies |
| Marianne Nygart | Board of Directors | 0 companies |
| Emma Frida Göransson | Board of Directors | 0 companies |
| Annika Cecilia Söderberg | Chairman | 0 companies |
| Sebastian Bille Christmas Poulsen | Chairman | 0 companies |
| Mattias Rolph Erik Segelmark | Board of Directors | 0 companies |
| Patrik Alexander Engblom | Chairman | 0 companies |
| Per Engelbrecht | Board of Directors | 0 companies |
| Magnus Gustav Jansson | Chairman | 0 companies |
| Andreas Göthberg | Chairman | 0 companies |